Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 40 out of 100. How common it is

Topic: Risk, prevention and care in population studies

Denmark is experiencing unprecedented population ageing, highlighting the importance of understanding age-related diseases, including dementia. Dementia is a syndrome characterised by progressive decline in cognitive function that interferes with daily activities and independent living. This study quantifies changes in dementia diagnosis across ages, time periods, and birth cohorts in Denmark. Using Danish registry data from 1986 to 2023, we analysed all individuals aged 50 and older, corresponding to the birth cohorts 1886-1973. We conducted an age-period-cohort analysis and stratified by sex. Dementia diagnosis was measured by either: 1) hospitalisation for dementia via ICD codes; or 2) filling at least two prescriptions for a dementia-related drug. Dementia diagnoses increased with age across cohorts and periods. The age effect showed rates beginning to rise around age 75 and peaking in the late 80s and early 90s. Looking at the period effect, incidence rates begin to increase in 1997 when the first dementia-related drugs became available, followed by a decrease in later years. Younger cohorts showed lower dementia incidence rates compared to older cohorts at similar ages, likely due to changes to modifiable risk factors. Findings from this study contribute to understanding dementia risks on the age, period, and cohort levels, and can inform public health policies aimed at diagnosing cognitive decline and improving quality of life for older populations.

Key findings

Why it matters

This age-period-cohort analysis found that younger cohorts in Denmark showed lower dementia incidence rates compared to older cohorts at similar ages, likely due to changes in modifiable risk factors. It also noted that dementia diagnoses increased with age and that incidence rates began to rise in 1997 when the first dementia-related drugs became available, followed by a decrease in later years.

Study details

How this study scored 40/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 38 of the 96 points it could be judged on, which is 40 of 100. Total 40 of 100.38 of the 96 points we could judge = 40 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 38 of the 96 points we could judge it on, which is 40 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Social Science & Medicine)
Journal's citation record 3 / 4 Social Science & Medicine: journal h-index 391 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 9.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Óskar Daði Jóhannsson holds only 2 work(s), too few to judge a track record — left out of this score
Institution's track record 0 / 3 University of Southern Denmark: institution h-index 692 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41539062)
Free to read 2 / 2 Free to read
Points 38 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 38 of the 96 points we could judge it on is 40 out of 100.
Total 40 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Callaway, J., Strozza, C., & Jóhannsson, Ó. D. (2026). Incidence of dementia diagnosis in Denmark, 1986–2023: an age-period-cohort analysis. Social Science & Medicine. https://doi.org/10.1016/j.socscimed.2026.118951

Vancouver

Callaway J, Strozza C, Jóhannsson ÓD. Incidence of dementia diagnosis in Denmark, 1986–2023: an age-period-cohort analysis. Social Science & Medicine. 2026. doi:10.1016/j.socscimed.2026.118951. PMID: 41539062.

BibTeX

@article{callaway2026-41539062,
  author  = {Callaway, Julia and Strozza, Cosmo and Jóhannsson, Óskar Daði},
  title   = {{Incidence of dementia diagnosis in Denmark, 1986–2023: an age-period-cohort analysis}},
  journal = {Social Science \& Medicine},
  year    = {2026},
  doi     = {10.1016/j.socscimed.2026.118951},
  pmid    = {41539062},
  url     = {https://doi.org/10.1016/j.socscimed.2026.118951}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in How common it is

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on How common it is

See all studies in How common it is →